Company Filing History:
1 out of 42 
1 out of 5,076 
1 out of 208 
Years Active: 2023
Title: The Innovative Contributions of Inventor Qi Zhou
Introduction
Qi Zhou is a notable inventor based in Hitchin, GB. He has made significant contributions to the field of biotechnology, particularly in the development of retroviral vectors for therapeutic applications. His work focuses on enhancing the efficacy of gene therapy and immune modulation.
Latest Patents
Qi Zhou holds a patent for a groundbreaking invention titled "Nipah virus envelope glycoprotein pseudotyped lentivirus." This invention relates to pseudotyped retrovirus-like particles or retroviral vectors that incorporate engineered envelope glycoproteins derived from the Paramyxoviridae family. These glycoproteins are fused to a cell targeting domain and a functional domain. The invention aims to selectively modulate the activity of specific subsets of cells, especially immune cells. The pseudotyped retrovirus-like particles or retroviral vectors are particularly beneficial for applications in gene therapy, immune therapy, and vaccination.
Career Highlights
Throughout his career, Qi Zhou has worked with prestigious institutions such as the Ecole Normale Superieure De Lyon and the Centre National De La Recherche Scientifique. His experience in these organizations has contributed to his expertise in the field of virology and gene therapy.
Collaborations
Qi Zhou has collaborated with notable colleagues, including Caroline Costa Fejoz and Els Verhoeyen. These collaborations have further enriched his research and development efforts in innovative therapeutic solutions.
Conclusion
In summary, Qi Zhou is an accomplished inventor whose work in developing pseudotyped retroviral vectors has the potential to revolutionize gene therapy and immune modulation. His contributions to biotechnology are significant and continue to impact the field positively.